Convened by the Robert J. Margolis, MD, Center for Health Policy at Duke University, the Second Annual Duke-Margolis Conference on Real-World Data and Evidence will bring together top experts and speakers to examine topics related to the use of real-world data (RWD) and evidence (RWE) in drug development and regulatory decision-making. Workshop sessions will highlight takeaways from two new white papers that will be released in conjunction with this conference (titles to be finalized):
- “Real-World Data Quality and Relevance: Characterizing Data for Regulatory Use” examines the process and factors that should be considered while characterizing RWD quality and relevancy for regulatory purposes
- “Applying Credible Observational RWE to Regulatory Decisions” focuses on the process for determining the regulatory acceptability of observational studies.
In-person and webcast registration are now open, with limited in-person seating available.
More information here.